NASDAQ:BPTSY

Biophytis (BPTSY) Stock Price, News & Analysis

$0.40 0.00 (0.00%)
As of 11/9/2026

About Biophytis Stock (NASDAQ:BPTSY)

Advanced

Key Stats

Today's Range
$0.40
▼
$0.40
50-Day Range
$0.25
▼
$0.40
52-Week Range
$0.40
▼
$0.40
Volume
1 shs
Average Volume
1,150 shs
Market Capitalization
$938.40 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Biophytis is a French biotechnology company focused on developing treatments for age-related diseases and conditions that affect muscle function and mobility. Founded in 2006, the company conducts research and development in France and has pursued clinical programs internationally.

Its best-known drug candidate is BIO101, also called Sarconeos, an oral small molecule designed to target biological pathways involved in muscle function. Biophytis has evaluated the candidate in clinical studies for sarcopenia, the age-related loss of muscle strength and mass, and for respiratory complications associated with COVID-19.

Biophytis’s work remains centered on developing therapies for conditions with limited treatment options; its investigational candidates are not established treatments.

AI Generated. May Contain Errors.

Receive BPTSY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biophytis and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BPTSY Stock News Headlines

Biophytis Files Half-Year Financial Report With SEC
Worse than socialism
Donald Trump and Bernie Sanders rarely agree on anything, yet both are steering the country toward the same economic system, according to veteran analyst Porter Stansberry. The government has already taken stakes in companies like Intel, Lithium Americas, and MP Materials, while political rhetoric on both sides points toward deeper centralization. Stansberry has spent months investigating what this bipartisan shift could mean for investors navigating the months ahead.tc pixel
See More Headlines

BPTSY Stock Analysis - Frequently Asked Questions

Biophytis' stock was trading at $0.0110 at the beginning of 2026. Since then, BPTSY stock has increased by 3,536.4% and is now trading at $0.40.

Company Calendar

Today
11/20/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:BPTSY
CIK
1768946
Fax
N/A
Employees
30
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.41
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($16.18) per share
Price / Book
-0.02

Miscellaneous

Outstanding Shares
2,346,000
Free Float
338,000
Market Cap
$938.40 thousand
Optionable
N/A
Beta
2.19
The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

This page (NASDAQ:BPTSY) was last updated on 11/9/2026 by MarketBeat.com Staff.
From Our Partners